Baidu
map

克利夫兰诊所发布过去十年的十大医学创新榜单

2015-10-28 徐青 译 健康界

2015年10月25日,第十届医学创新峰会(Medical Innovations Summit)在克利夫兰会议中心(Cleveland Convention Center)召开,由克利夫兰诊所医生组成的咨询小组列出了过去十年的十大医学创新榜单。1.利用大数据改善医疗(2011)随着美国各医院都开始采用电子病历,大数据也成了一门大生意。研究人员正在使用计算机分析这些病历,以期发现疾病谱、治疗方法等

2015年10月25日,第十届医学创新峰会(Medical Innovations Summit)在克利夫兰会议中心(Cleveland Convention Center)召开,由克利夫兰诊所医生组成的咨询小组列出了过去十年的十大医学创新榜单。

1.利用大数据改善医疗(2011)

随着美国各医院都开始采用电子病历,大数据也成了一门大生意。研究人员正在使用计算机分析这些病历,以期发现疾病谱、治疗方法等并识别出最佳治疗方案。

很多大公司,如IBM也扩展到了这一行业,开始提供医疗分析服务。与此同时,新的可穿戴设备也收集了更多的健康数据供分析参考。

IQ4I Researchand Consultancy最近的一项研究发现,未来四年,医疗数据分析中投入的资金还会上涨40%,将成为一个价值超过200亿美元的全球市场。

2.丙型肝炎治疗新时代(2014)

据估计,世界上有1.7亿人感染丙型肝炎。丙型肝炎不易察觉,但会逐步损害患者的肝脏的。过去几十年里,基于干扰素的治疗方法成功率很低。但是,新型的无干扰素治疗则有效得多,给了医生根除这种疾病的希望。

3.肥胖外科手术控制糖尿病(2013)

糖尿病是一种慢性病,每天有几百万人受此病折磨。肥胖外科手术给对抗糖尿病带来了希望。研究人员对肥胖手术控制控制糖尿病的效果进行了长期研究,他们发现手术五年后,有一半以上的的二型糖尿病患者完全或部分缓解。

4.经皮主动脉心脏瓣膜(2008)

这是开心脏手术的一个备选,现在已经成了很多高危心脏病患者的标准治疗方案。
通过使用导管,医生可以将丝网阀(wire mesh valve)通过动脉插入心脏,代替被损害的瓣膜。FDA认证的主动脉瓣有四种,可用于经皮修复或置换手术。这项技术也可用于经皮二尖瓣修复术。今年仍有一些设备在等待FDA的认证。

5.生产抗流感疫苗新政策(2009)

一项新疫苗政策不仅可以对抗一种致命流感病毒,还能帮助医疗工作者对抗流行病。研究人员使用禽流感病毒的模拟版本(类病毒颗粒,VLP)来预防禽流感。因为不需要活病毒,类病毒颗粒的疫苗生产更容易、更快速。公共卫生专家也可以更快捷地应对感染警告。2014年,科学家开始使用VLP政策生产埃博拉疫苗,预计2016年将面世。

6.检查点抑制剂(2015)

2014年,克利夫兰诊所的医生发现了免疫检查点抑制剂的潜力--对抗癌症。从那之后,已证明三种免疫检查点抑制剂可用于患有黑素瘤的患者。2014年,三种抑制剂的销售额超过了15亿美元,其中一种还获得了对肺癌患者使用的优先审查权。此外,现有80多家公司在研究148中免疫检查点抑制剂对于多种癌症的疗效,有十种已经进入了最后的临床实验阶段。

7.用于将胆固醇的PCSK9抑制剂(2015)

这种新型降胆固醇药物最近获得了FDA认证。所有LDL(低密度胆固醇)水平过高的患者中,有17%可以使用这种药物,有可能创造一个价值30亿的市场。

8.双源CT(Dual Energy Source Computed Tomography)(2008)

双源CT的特点是有两个X光源和两个辐射探测器,在减少辐射的基础上迅速成像。心律较高或不规律的患者拍摄CT本来就较难,双源CT的速度使得这些患者成像成为可能。医生正在将这项技术用于血管成像、CT结肠成像和一些癌症。

克利夫兰诊所的健康总监迈克尔·罗伊森(Michael Roizen)说:“以前用几个小时才能拿到的扫描图,现在只需要一杯咖啡的时间。”

9.视网膜假体(2014)

现在世界上已经有130多名患者成功植入了视网膜假体。目前,除了由于色素性视网膜炎而失明的患者之外,视网膜假体开始在其他疾病导致的明患者身上进行实验。2015年初发布的长期研究结果证实,使用视网膜假体后,这些患者的生活质量和自理能力都有很大提高。

10.基因指导的实体瘤诊断(2014)

在不断的研究下,基因检测可以用于多种类型的癌症治疗,其中包括头部、肺、甲状腺和胰腺部位的黑素瘤和肿瘤。很多临床实验正在检测将使用基因进行肿瘤检测和数据库相结合的治疗效果,该数据库中收集的数据根据基因而非癌症类型对比了治疗方法。到2016年,基因指导的肿瘤诊断将会获得260亿的市场价值。

回顾了过去,也该展望一下未来。在今日的闭幕式上,克利夫兰还会发布其预测的未来十年十大医疗创新榜单。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1704983, encodeId=2c3b1e049832c, content=<a href='/topic/show?id=0d5c6293544' target=_blank style='color:#2F92EE;'>#榜单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62935, encryptionId=0d5c6293544, topicName=榜单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d7a30920910, createdName=gwc393, createdTime=Mon Jan 11 09:59:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735853, encodeId=ae741e3585386, content=<a href='/topic/show?id=f8022886617' target=_blank style='color:#2F92EE;'>#克利夫兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28866, encryptionId=f8022886617, topicName=克利夫兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=846834021388, createdName=s_pl2019, createdTime=Thu Oct 13 00:59:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690325, encodeId=544016903257d, content=<a href='/topic/show?id=92a83404183' target=_blank style='color:#2F92EE;'>#医学创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34041, encryptionId=92a83404183, topicName=医学创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3af529038789, createdName=lifestar, createdTime=Tue Dec 08 12:59:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285230, encodeId=8952128523074, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri Oct 30 06:59:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310949, encodeId=81971310949da, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Fri Oct 30 06:59:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41880, encodeId=ee074188021, content=技术进步日新月异,我等屌丝得跟上才是!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG56284F436A2E92816.jpg, createdBy=30661658215, createdName=糖果鱼塘, createdTime=Thu Oct 29 12:29:00 CST 2015, time=2015-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41823, encodeId=256541823a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Wed Oct 28 22:36:00 CST 2015, time=2015-10-28, status=1, ipAttribution=)]
    2016-01-11 gwc393
  2. [GetPortalCommentsPageByObjectIdResponse(id=1704983, encodeId=2c3b1e049832c, content=<a href='/topic/show?id=0d5c6293544' target=_blank style='color:#2F92EE;'>#榜单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62935, encryptionId=0d5c6293544, topicName=榜单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d7a30920910, createdName=gwc393, createdTime=Mon Jan 11 09:59:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735853, encodeId=ae741e3585386, content=<a href='/topic/show?id=f8022886617' target=_blank style='color:#2F92EE;'>#克利夫兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28866, encryptionId=f8022886617, topicName=克利夫兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=846834021388, createdName=s_pl2019, createdTime=Thu Oct 13 00:59:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690325, encodeId=544016903257d, content=<a href='/topic/show?id=92a83404183' target=_blank style='color:#2F92EE;'>#医学创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34041, encryptionId=92a83404183, topicName=医学创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3af529038789, createdName=lifestar, createdTime=Tue Dec 08 12:59:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285230, encodeId=8952128523074, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri Oct 30 06:59:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310949, encodeId=81971310949da, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Fri Oct 30 06:59:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41880, encodeId=ee074188021, content=技术进步日新月异,我等屌丝得跟上才是!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG56284F436A2E92816.jpg, createdBy=30661658215, createdName=糖果鱼塘, createdTime=Thu Oct 29 12:29:00 CST 2015, time=2015-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41823, encodeId=256541823a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Wed Oct 28 22:36:00 CST 2015, time=2015-10-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1704983, encodeId=2c3b1e049832c, content=<a href='/topic/show?id=0d5c6293544' target=_blank style='color:#2F92EE;'>#榜单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62935, encryptionId=0d5c6293544, topicName=榜单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d7a30920910, createdName=gwc393, createdTime=Mon Jan 11 09:59:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735853, encodeId=ae741e3585386, content=<a href='/topic/show?id=f8022886617' target=_blank style='color:#2F92EE;'>#克利夫兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28866, encryptionId=f8022886617, topicName=克利夫兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=846834021388, createdName=s_pl2019, createdTime=Thu Oct 13 00:59:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690325, encodeId=544016903257d, content=<a href='/topic/show?id=92a83404183' target=_blank style='color:#2F92EE;'>#医学创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34041, encryptionId=92a83404183, topicName=医学创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3af529038789, createdName=lifestar, createdTime=Tue Dec 08 12:59:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285230, encodeId=8952128523074, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri Oct 30 06:59:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310949, encodeId=81971310949da, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Fri Oct 30 06:59:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41880, encodeId=ee074188021, content=技术进步日新月异,我等屌丝得跟上才是!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG56284F436A2E92816.jpg, createdBy=30661658215, createdName=糖果鱼塘, createdTime=Thu Oct 29 12:29:00 CST 2015, time=2015-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41823, encodeId=256541823a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Wed Oct 28 22:36:00 CST 2015, time=2015-10-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1704983, encodeId=2c3b1e049832c, content=<a href='/topic/show?id=0d5c6293544' target=_blank style='color:#2F92EE;'>#榜单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62935, encryptionId=0d5c6293544, topicName=榜单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d7a30920910, createdName=gwc393, createdTime=Mon Jan 11 09:59:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735853, encodeId=ae741e3585386, content=<a href='/topic/show?id=f8022886617' target=_blank style='color:#2F92EE;'>#克利夫兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28866, encryptionId=f8022886617, topicName=克利夫兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=846834021388, createdName=s_pl2019, createdTime=Thu Oct 13 00:59:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690325, encodeId=544016903257d, content=<a href='/topic/show?id=92a83404183' target=_blank style='color:#2F92EE;'>#医学创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34041, encryptionId=92a83404183, topicName=医学创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3af529038789, createdName=lifestar, createdTime=Tue Dec 08 12:59:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285230, encodeId=8952128523074, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri Oct 30 06:59:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310949, encodeId=81971310949da, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Fri Oct 30 06:59:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41880, encodeId=ee074188021, content=技术进步日新月异,我等屌丝得跟上才是!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG56284F436A2E92816.jpg, createdBy=30661658215, createdName=糖果鱼塘, createdTime=Thu Oct 29 12:29:00 CST 2015, time=2015-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41823, encodeId=256541823a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Wed Oct 28 22:36:00 CST 2015, time=2015-10-28, status=1, ipAttribution=)]
    2015-10-30 lilianxiang
  5. [GetPortalCommentsPageByObjectIdResponse(id=1704983, encodeId=2c3b1e049832c, content=<a href='/topic/show?id=0d5c6293544' target=_blank style='color:#2F92EE;'>#榜单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62935, encryptionId=0d5c6293544, topicName=榜单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d7a30920910, createdName=gwc393, createdTime=Mon Jan 11 09:59:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735853, encodeId=ae741e3585386, content=<a href='/topic/show?id=f8022886617' target=_blank style='color:#2F92EE;'>#克利夫兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28866, encryptionId=f8022886617, topicName=克利夫兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=846834021388, createdName=s_pl2019, createdTime=Thu Oct 13 00:59:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690325, encodeId=544016903257d, content=<a href='/topic/show?id=92a83404183' target=_blank style='color:#2F92EE;'>#医学创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34041, encryptionId=92a83404183, topicName=医学创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3af529038789, createdName=lifestar, createdTime=Tue Dec 08 12:59:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285230, encodeId=8952128523074, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri Oct 30 06:59:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310949, encodeId=81971310949da, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Fri Oct 30 06:59:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41880, encodeId=ee074188021, content=技术进步日新月异,我等屌丝得跟上才是!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG56284F436A2E92816.jpg, createdBy=30661658215, createdName=糖果鱼塘, createdTime=Thu Oct 29 12:29:00 CST 2015, time=2015-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41823, encodeId=256541823a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Wed Oct 28 22:36:00 CST 2015, time=2015-10-28, status=1, ipAttribution=)]
    2015-10-30 ycmayy
  6. [GetPortalCommentsPageByObjectIdResponse(id=1704983, encodeId=2c3b1e049832c, content=<a href='/topic/show?id=0d5c6293544' target=_blank style='color:#2F92EE;'>#榜单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62935, encryptionId=0d5c6293544, topicName=榜单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d7a30920910, createdName=gwc393, createdTime=Mon Jan 11 09:59:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735853, encodeId=ae741e3585386, content=<a href='/topic/show?id=f8022886617' target=_blank style='color:#2F92EE;'>#克利夫兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28866, encryptionId=f8022886617, topicName=克利夫兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=846834021388, createdName=s_pl2019, createdTime=Thu Oct 13 00:59:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690325, encodeId=544016903257d, content=<a href='/topic/show?id=92a83404183' target=_blank style='color:#2F92EE;'>#医学创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34041, encryptionId=92a83404183, topicName=医学创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3af529038789, createdName=lifestar, createdTime=Tue Dec 08 12:59:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285230, encodeId=8952128523074, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri Oct 30 06:59:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310949, encodeId=81971310949da, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Fri Oct 30 06:59:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41880, encodeId=ee074188021, content=技术进步日新月异,我等屌丝得跟上才是!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG56284F436A2E92816.jpg, createdBy=30661658215, createdName=糖果鱼塘, createdTime=Thu Oct 29 12:29:00 CST 2015, time=2015-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41823, encodeId=256541823a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Wed Oct 28 22:36:00 CST 2015, time=2015-10-28, status=1, ipAttribution=)]
    2015-10-29 糖果鱼塘

    技术进步日新月异,我等屌丝得跟上才是!!!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1704983, encodeId=2c3b1e049832c, content=<a href='/topic/show?id=0d5c6293544' target=_blank style='color:#2F92EE;'>#榜单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62935, encryptionId=0d5c6293544, topicName=榜单)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d7a30920910, createdName=gwc393, createdTime=Mon Jan 11 09:59:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1735853, encodeId=ae741e3585386, content=<a href='/topic/show?id=f8022886617' target=_blank style='color:#2F92EE;'>#克利夫兰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28866, encryptionId=f8022886617, topicName=克利夫兰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=846834021388, createdName=s_pl2019, createdTime=Thu Oct 13 00:59:00 CST 2016, time=2016-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690325, encodeId=544016903257d, content=<a href='/topic/show?id=92a83404183' target=_blank style='color:#2F92EE;'>#医学创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34041, encryptionId=92a83404183, topicName=医学创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3af529038789, createdName=lifestar, createdTime=Tue Dec 08 12:59:00 CST 2015, time=2015-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285230, encodeId=8952128523074, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri Oct 30 06:59:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310949, encodeId=81971310949da, content=<a href='/topic/show?id=39be91564e5' target=_blank style='color:#2F92EE;'>#诊所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91564, encryptionId=39be91564e5, topicName=诊所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c805395, createdName=ycmayy, createdTime=Fri Oct 30 06:59:00 CST 2015, time=2015-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41880, encodeId=ee074188021, content=技术进步日新月异,我等屌丝得跟上才是!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151022/IMG56284F436A2E92816.jpg, createdBy=30661658215, createdName=糖果鱼塘, createdTime=Thu Oct 29 12:29:00 CST 2015, time=2015-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=41823, encodeId=256541823a8, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Wed Oct 28 22:36:00 CST 2015, time=2015-10-28, status=1, ipAttribution=)]
    2015-10-28 sanshengshi

    0

相关资讯

谁才真正是全球年度更具智慧的科技公司?

定义什么是智慧的公司,这或许听起来很难。但当你看到一个这样的公司时,你就知道了。当这样的公司将一项真正创新的技术商业化时,不可思议的事情就发生了:市场中领导者的地位得到巩固或被别的公司所取代。竞争者们必须重新定义或重新思考他们的战略。当我们汇编TR50榜单(全球最具智慧的50家科技公司)时,我们所关注的就是这些。我们并不清点公司所拥有的专利或雇佣的博士。我们会问,这个公司在过去的一年中,有没有

2014年互联网发展的九大趋势 智慧医疗名列其中

对比2013年,他们提到了颠覆:移动创业的机会将不再局限于App这种形态,O2O也将通过粉丝聚集模式彻底改变,三、四线城市的年轻草根创业者还拥有大 把商机,2013年的海外IPO与并购潮将在今年继续。他们也提到了回归理性:电商在极速前进之后需要回归经营本质,智能医疗目前仍难以改变人们的就医方式,互联网与金融的融合远没有尘埃落定。美国部分呈现了更多niche market:烹饪书籍、自我众

MIT科技评论:2014年科技界的六大失败!

托尔斯泰曾经说过,幸福的家庭都是相似的,但不幸的家庭各不相同! 在科学技术界,这个魔咒也不例外:所有成功的技术是一样的,但是失败的技术却各不相同。 无论是安装在十亿部智能手机的一项应用还是仅由部分科学家开展专业工作,成功意味着解决了一个技术问题。  当我们过去总是被各种新鲜的技术突破新闻包围时,事实上大多数技术失败了,尤其是那些不能达成规模化应用的技术。 在科学界

大数据时代,美国医院评价给国内智慧医疗的几点启发

更精确的数据采集和应用,更立体的医院评价体系,更明确的患者导向,是大数据时代美国医院评价带给中国的鲜活启示。 2015年7月21日,《美国新闻与世界报道》公布了美国2015-2016年最佳医院排名。紧随其后的7月22日,由中国医学科学院、中国研究型医院学会主办的现代化医院评价与评估高峰论坛举行,国家卫计委医疗管理服务指导中心主任赵明钢指出,中国将基于数据,科学、规范和准确地建立全国医疗机

制造低成本的高性能义肢,帮助发展中国家的残疾人

“有时候,人们对于发展中国家的技术抱持的相当然的想法让我感到困扰,”阿莫斯·温特说,“他们以为你可以用一堆废弃的零件胡乱组装一下,让几个本科生在一个学期里把它搞定,然后你可以把它免费送出去。但实际情况可能无一如此。” 温特因为创造出了一台针对贫困国家民众的轮椅而受到关注。这台轮椅在崎岖不平的道路上走得足够稳,在室内环境里可以自如地转悠。温特的这个创意产生于2005年,当时还是麻省理工

你有必要了解下苹果通往未来医疗的这条通道:ResearchKit

苹果在3月10日凌晨的发布会上除了公布了Apple Watch发售细节以及发布了全新的Macbook外,还带来了全新的医疗项目ResearchKit。简单来讲,ResearchKit是苹果专为医学研究者打造的一款软件基础架构。其相比针对个人的健康监控iHealth更进一步,通过于全球顶尖的医疗机构合作建立强大的数据库,进行进一步的医学研究和诊疗等。 苹果方面介绍,患者可以借助iPhone通过

Baidu
map
Baidu
map
Baidu
map